Daewoong Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Daewoong.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 38.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Daewoong Co., Ltd. (KRX:003090) Held Back By Insufficient Growth Even After Shares Climb 26%
Sep 01Daewoong Co., Ltd.'s (KRX:003090) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jul 14Is Daewoong (KRX:003090) Using Too Much Debt?
Jul 04Does Daewoong (KRX:003090) Have A Healthy Balance Sheet?
Apr 02With EPS Growth And More, Daewoong (KRX:003090) Is Interesting
Apr 13A Look At The Intrinsic Value Of Daewoong Co., Ltd. (KRX:003090)
Mar 29Daewoong Co., Ltd. (KRX:003090) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Mar 14Daewoong (KRX:003090) Seems To Use Debt Quite Sensibly
Feb 21The Daewoong (KRX:003090) Share Price Has Soared 308%, Delighting Many Shareholders
Jan 31Do Its Financials Have Any Role To Play In Driving Daewoong Co., Ltd.'s (KRX:003090) Stock Up Recently?
Dec 04In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Daewoong has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 1,825,714 | 118,195 | -164,306 | 161,068 | N/A |
3/31/2024 | 1,821,844 | 135,340 | -33,830 | 218,599 | N/A |
12/31/2023 | 1,813,841 | 152,665 | -22,490 | 205,655 | N/A |
9/30/2023 | 1,811,723 | 123,049 | 68,111 | 228,147 | N/A |
6/30/2023 | 1,783,012 | 122,647 | 52,987 | 191,958 | N/A |
3/31/2023 | 1,735,656 | 117,547 | 11,157 | 145,438 | N/A |
12/31/2022 | 1,697,338 | 102,566 | 32,788 | 149,082 | N/A |
9/30/2022 | 1,657,478 | 124,723 | 392 | 132,746 | N/A |
6/30/2022 | 1,600,944 | 112,646 | 36,629 | 149,775 | N/A |
3/31/2022 | 1,560,377 | 99,018 | 26,202 | 151,077 | N/A |
12/31/2021 | 1,511,374 | 78,730 | 17,866 | 133,175 | N/A |
9/30/2021 | 1,451,197 | 105,593 | 35,115 | 115,866 | N/A |
6/30/2021 | 1,428,068 | 94,024 | 38,115 | 123,389 | N/A |
3/31/2021 | 1,375,581 | 86,028 | 51,902 | 118,843 | N/A |
12/31/2020 | 1,355,337 | 98,379 | 82,383 | 145,366 | N/A |
9/30/2020 | 1,362,729 | 49,531 | 47,566 | 109,128 | N/A |
6/30/2020 | 1,343,957 | 45,569 | 42,613 | 111,926 | N/A |
3/31/2020 | 1,375,384 | 65,058 | 55,589 | 128,422 | N/A |
12/31/2019 | 1,365,679 | 61,493 | 57,736 | 138,512 | N/A |
9/30/2019 | 1,339,502 | 41,771 | 107,061 | 176,956 | N/A |
6/30/2019 | 1,313,898 | 44,530 | 62,728 | 135,359 | N/A |
3/31/2019 | 1,261,879 | 27,355 | 11,991 | 80,623 | N/A |
12/31/2018 | 1,231,290 | 29,863 | -24,930 | 45,381 | N/A |
9/30/2018 | 1,186,059 | 68,359 | 4,313 | 80,421 | N/A |
6/30/2018 | 1,171,372 | 68,406 | -9,621 | 83,812 | N/A |
3/31/2018 | 1,149,164 | 67,927 | N/A | 132,827 | N/A |
12/31/2017 | 1,123,957 | 66,251 | N/A | 147,774 | N/A |
9/30/2017 | 1,113,711 | 53,527 | N/A | 96,422 | N/A |
6/30/2017 | 1,076,124 | 49,187 | N/A | 58,243 | N/A |
3/31/2017 | 1,036,113 | 34,188 | N/A | 20,582 | N/A |
12/31/2016 | 1,014,966 | 19,831 | N/A | 18,756 | N/A |
9/30/2016 | 996,885 | 10,688 | N/A | 15,855 | N/A |
6/30/2016 | 1,002,592 | 11,074 | N/A | 66,398 | N/A |
3/31/2016 | 997,332 | 25,784 | N/A | 84,569 | N/A |
12/31/2015 | 996,757 | 38,623 | N/A | 74,916 | N/A |
9/30/2015 | 978,600 | 35,386 | N/A | 55,691 | N/A |
6/30/2015 | 945,037 | 26,648 | N/A | 52,953 | N/A |
3/31/2015 | 925,511 | 24,480 | N/A | 55,049 | N/A |
12/31/2014 | 893,953 | 23,811 | N/A | 46,607 | N/A |
9/30/2014 | 879,699 | 25,540 | N/A | 62,201 | N/A |
6/30/2014 | 866,072 | 36,765 | N/A | 43,394 | N/A |
3/31/2014 | 848,551 | 41,186 | N/A | 53,178 | N/A |
12/31/2013 | 843,315 | 40,772 | N/A | 86,194 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A003090's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if A003090's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A003090's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A003090's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A003090's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A003090's Return on Equity is forecast to be high in 3 years time